Nidan Laboratories and Healthcare Limited (NSE:NIDAN)
12.95
+0.40 (3.19%)
Oct 1, 2026, 3:12 PM IST
NSE:NIDAN Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 179 | 177 | 230 | 376 | 471 | 461 | |
Market Cap Growth | -29.32% | -22.96% | -38.82% | -20.09% | 1.96% | - |
Enterprise Value | 271 | 284 | 320 | 454 | 538 | 742 |
Last Close Price | 12.90 | 12.75 | 16.55 | 27.05 | 33.85 | 33.20 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 11.94 | 11.77 | 11.64 | - | 13.29 | 17.33 |
PS Ratio | 0.70 | 0.69 | 0.94 | 1.56 | 1.94 | 1.56 |
PB Ratio | 0.26 | 0.25 | 0.34 | 0.57 | 0.68 | 0.70 |
P/TBV Ratio | 0.26 | 0.26 | 0.35 | 0.58 | 0.69 | 0.70 |
P/FCF Ratio | 15.06 | 14.89 | 16.20 | 7.86 | 4.57 | 61.27 |
P/OCF Ratio | 10.76 | 10.63 | 9.75 | 6.81 | 4.29 | 5.90 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.06 | 1.11 | 1.30 | 1.88 | 2.22 | 2.50 |
EV/EBITDA Ratio | 5.58 | 5.85 | 6.12 | 7.06 | 7.92 | 7.88 |
EV/EBIT Ratio | 9.13 | 9.58 | 11.33 | 12.69 | 14.51 | 10.93 |
EV/FCF Ratio | 22.77 | 23.88 | 22.52 | 9.49 | 5.22 | 98.46 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.16 | 0.16 | 0.16 | 0.19 | 0.16 | 0.29 |
Debt / EBITDA Ratio | 2.30 | 2.30 | 2.13 | 1.93 | 1.61 | 2.05 |
Debt / FCF Ratio | 9.38 | 9.38 | 7.83 | 2.60 | 1.06 | 25.62 |
Net Debt / Equity Ratio | 0.13 | 0.13 | 0.14 | 0.14 | 0.04 | 0.17 |
Net Debt / EBITDA Ratio | 1.89 | 1.89 | 1.76 | 1.49 | 0.37 | 1.19 |
Net Debt / FCF Ratio | 7.70 | 7.70 | 6.49 | 2.00 | 0.24 | 14.86 |
Asset Turnover | 0.31 | 0.31 | 0.30 | 0.29 | 0.28 | 0.42 |
Inventory Turnover | 4.23 | 4.23 | 4.60 | 6.58 | 8.49 | 23.45 |
Quick Ratio | 0.47 | 0.47 | 0.38 | 0.37 | 1.64 | 1.16 |
Current Ratio | 1.43 | 1.43 | 1.10 | 2.68 | 2.18 | 1.98 |
Return on Equity (ROE) | 2.19% | 2.19% | 2.94% | -4.77% | 5.23% | 6.72% |
Return on Assets (ROA) | 2.22% | 2.22% | 2.13% | 2.68% | 2.68% | 6.02% |
Return on Invested Capital (ROIC) | 2.32% | 2.34% | 2.64% | 4.84% | 3.66% | 6.69% |
Return on Capital Employed (ROCE) | 4.00% | 4.00% | 3.90% | 5.00% | 5.00% | 9.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 8.40% | 8.50% | 8.59% | -8.60% | 7.52% | 5.77% |
FCF Yield | 6.64% | 6.72% | 6.17% | 12.72% | 21.89% | 1.63% |
Buyback Yield / Dilution | - | - | - | - | -21.22% | -15.83% |